These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8219482)

  • 1. Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver-Russell syndrome: analysis of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Chatelain PG
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():79-81. PubMed ID: 8219482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Price DA; Albertsson-Wikland K
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():69-74. PubMed ID: 8219480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O; Lindberg A; Cole T
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():82-8; discussion 89. PubMed ID: 8219483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of children with idiopathic short stature in the Kabi Pharmacia International Growth Study, and their response to growth hormone treatment. International Board of the Kabi Pharmacia International Growth Study.
    Albertsson-Wikland K
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():75-8. PubMed ID: 8219481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
    Ranke MB; Lindberg A;
    Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment of short children born small for gestational age or with Silver-Russell syndrome: results from KIGS (Kabi International Growth Study), including the first report on final height.
    Ranke MB; Lindberg A
    Acta Paediatr Suppl; 1996 Oct; 417():18-26. PubMed ID: 9055904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW).
    Rakover Y; Dietsch S; Ambler GR; Chock C; Thomsett M; Cowell CT
    Eur J Pediatr; 1996 Oct; 155(10):851-7. PubMed ID: 8891553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study.
    Ranke MB; Lindberg A
    Acta Paediatr Suppl; 1994 Dec; 406():18-23; discussion 24. PubMed ID: 7734807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O
    Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who is treated with growth hormone today? The Executive Scientific Committee of the Kabi International Growth Study.
    Vanderschueren-Lodeweyckx M
    Acta Paediatr Scand Suppl; 1990; 370():107-13; discussion 114. PubMed ID: 2260448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study.
    Gluckman PD; Gunn AJ; Wray A; Cutfield WS; Chatelain PG; Guilbaud O; Ambler GR; Wilton P; Albertsson-Wikland K
    J Pediatr; 1992 Dec; 121(6):920-3. PubMed ID: 1447657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation.
    Stanhope R; Ackland F; Hamill G; Clayton J; Jones J; Preece MA
    Acta Paediatr Scand Suppl; 1989; 349():47-52; discussion 53-4. PubMed ID: 2750531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear growth in response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: the National Cooperative Growth Study experience.
    Chernausek SD; Breen TJ; Frank GR
    J Pediatr; 1996 May; 128(5 Pt 2):S22-7. PubMed ID: 8627464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment in Aarskog syndrome: analysis of the KIGS (Pharmacia International Growth Database) data.
    Darendeliler F; Larsson P; Neyzi O; Price AD; Hagenäs L; Sipilä I; Lindgren AC; Otten B; Bakker B;
    J Pediatr Endocrinol Metab; 2003; 16(8):1137-42. PubMed ID: 14594174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intra-uterine growth retardation: an indication for treatment with growth hormone?].
    Hokken-Koelega AC
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):173-6. PubMed ID: 1448807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation].
    Vicens-Calvet E; Seijo G; Potau N; de los Llanos Moreno M; Carrascosa A
    Med Clin (Barc); 1999 May; 112(16):601-5. PubMed ID: 10374174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R; Bakker B; Lundberg M; Doerr HG
    Pediatr Rehabil; 2006; 9(2):144-8. PubMed ID: 16449073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Czernichow P; Fjellestad-Paulsen A
    Horm Res; 1998; 49 Suppl 2():23-7. PubMed ID: 9730668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.